Day: March 17, 2020
Most Read
Near-lockdown in the Bay Area ‘ratchets up’ challenges for local biotechs and labs
STAT Plus: Biotech in the time of the coronavirus: A semi-regular column on the outbreak’s impact on drug makers
A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data
STAT Plus: Pharmalittle: FDA gives states an OK to authorize coronavirus tests; more companies race to combat Covid-19
STAT Plus: Merck drug reduces cough frequency but taste alterations could cloud prospects
Regeneron says potential Covid-19 drugs could start human tests by early summer
How much coronavirus data does Moderna need? Plus: CureVac has an interesting month
All Coverage
